Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 179

1.

Modification of pfap2μ and pfubp1 markedly reduces ring-stage susceptibility of Plasmodium falciparum to artemisinin in vitro.

Henrici RC, van Schalkwyk DA, Sutherland CJ.

Antimicrob Agents Chemother. 2019 Oct 21. pii: AAC.01542-19. doi: 10.1128/AAC.01542-19. [Epub ahead of print]

PMID:
31636063
2.

The Effect of Robot Attentional Behaviors on User Perceptions and Behaviors in a Simulated Health Care Interaction: Randomized Controlled Trial.

Johanson DL, Ahn HS, MacDonald BA, Ahn BK, Lim J, Hwang E, Sutherland CJ, Broadbent E.

J Med Internet Res. 2019 Oct 4;21(10):e13667. doi: 10.2196/13667.

4.

Rapid and iterative genome editing in the malaria parasite Plasmodium knowlesi provides new tools for P. vivax research.

Mohring F, Hart MN, Rawlinson TA, Henrici R, Charleston JA, Diez Benavente E, Patel A, Hall J, Almond N, Campino S, Clark TG, Sutherland CJ, Baker DA, Draper SJ, Moon RW.

Elife. 2019 Jun 17;8. pii: e45829. doi: 10.7554/eLife.45829.

5.

Genetic dissociation of three antigenic genes in Plasmodium ovale curtisi and Plasmodium ovale wallikeri.

Saralamba N, Nosten F, Sutherland CJ, Arez AP, Snounou G, White NJ, Day NPJ, Dondorp AM, Imwong M.

PLoS One. 2019 Jun 6;14(6):e0217795. doi: 10.1371/journal.pone.0217795. eCollection 2019.

6.

An analysis of large structural variation in global Plasmodium falciparum isolates identifies a novel duplication of the chloroquine resistance associated gene.

Ravenhall M, Benavente ED, Sutherland CJ, Baker DA, Campino S, Clark TG.

Sci Rep. 2019 Jun 4;9(1):8287. doi: 10.1038/s41598-019-44599-0.

7.

Mosquito and human hepatocyte infections with Plasmodium ovale curtisi and Plasmodium ovale wallikeri.

Kristan M, Thorburn SG, Hafalla JC, Sutherland CJ, Oguike MC.

Trans R Soc Trop Med Hyg. 2019 Oct 11;113(10):617-622. doi: 10.1093/trstmh/trz048.

PMID:
31162595
8.

Utilizing Multiple BioMEMS Sensors to Monitor Orthopaedic Strain and Predict Bone Fracture Healing.

Wolynski JG, Sutherland CJ, Demir HV, Unal E, Alipour A, Puttlitz CM, McGilvray KC.

J Orthop Res. 2019 Sep;37(9):1873-1880. doi: 10.1002/jor.24325. Epub 2019 May 17.

PMID:
31042313
9.

Molecular quantification of Plasmodium parasite density from the blood retained in used RDTs.

Robinson A, Busula AO, Muwanguzi JK, Powers SJ, Masiga DK, Bousema T, Takken W, de Boer JG, Logan JG, Beshir KB, Sutherland CJ.

Sci Rep. 2019 Mar 25;9(1):5107. doi: 10.1038/s41598-019-41438-0.

10.

Artemisinin resistance-associated markers in Plasmodium falciparum parasites from the China-Myanmar border: predicted structural stability of K13 propeller variants detected in a low-prevalence area.

He Y, Campino S, Diez Benavente E, Warhurst DC, Beshir KB, Lubis I, Gomes AR, Feng J, Jiazhi W, Sun X, Huang F, Tang LH, Sutherland CJ, Clark TG.

PLoS One. 2019 Mar 18;14(3):e0213686. doi: 10.1371/journal.pone.0213686. eCollection 2019.

11.

Imported malaria: key messages in an era of elimination.

Rampling T, Sutherland CJ, Whitty CJ.

Clin Med (Lond). 2019 Mar;19(2):153-156. doi: 10.7861/clinmedicine.19-2-153.

12.

A new window on Plasmodium malariae infections.

Sutherland CJ.

J Infect Dis. 2019 Mar 10. pii: jiz103. doi: 10.1093/infdis/jiz103. [Epub ahead of print] No abstract available.

PMID:
30855671
13.

Plasmodium knowlesi exhibits distinct in vitro drug susceptibility profiles from those of Plasmodium falciparum.

van Schalkwyk DA, Blasco B, Davina Nuñez R, Liew JWK, Amir A, Lau YL, Leroy D, Moon RW, Sutherland CJ.

Int J Parasitol Drugs Drug Resist. 2019 Apr;9:93-99. doi: 10.1016/j.ijpddr.2019.02.004. Epub 2019 Feb 22.

14.

Immune Responses to the Sexual Stages of Plasmodium falciparum Parasites.

Kengne-Ouafo JA, Sutherland CJ, Binka FN, Awandare GA, Urban BC, Dinko B.

Front Immunol. 2019 Feb 11;10:136. doi: 10.3389/fimmu.2019.00136. eCollection 2019. Review.

15.

Low Levels of Human Antibodies to Gametocyte-Infected Erythrocytes Contrasts the PfEMP1-Dominant Response to Asexual Stages in P. falciparum Malaria.

Chan JA, Drew DR, Reiling L, Lisboa-Pinto A, Dinko B, Sutherland CJ, Dent AE, Chelimo K, Kazura JW, Boyle MJ, Beeson JG.

Front Immunol. 2019 Jan 14;9:3126. doi: 10.3389/fimmu.2018.03126. eCollection 2018.

16.

Transient temperature fluctuations severely decrease P. falciparum susceptibility to artemisinin in vitro.

Henrici RC, van Schalkwyk DA, Sutherland CJ.

Int J Parasitol Drugs Drug Resist. 2019 Apr;9:23-26. doi: 10.1016/j.ijpddr.2018.12.003. Epub 2018 Dec 16.

17.

Alternative pathway to reduced artemisinin susceptibility in Plasmodium falciparum.

Henrici RC, Sutherland CJ.

Proc Natl Acad Sci U S A. 2018 Dec 11;115(50):12556-12558. doi: 10.1073/pnas.1818287115. Epub 2018 Nov 28. No abstract available.

18.

Geographical and temporal trends and seasonal relapse in Plasmodium ovale spp. and Plasmodium malariae infections imported to the UK between 1987 and 2015.

Nabarro LEB, Nolder D, Broderick C, Nadjm B, Smith V, Blaze M, Checkley AM, Chiodini PL, Sutherland CJ, Whitty CJM.

BMC Med. 2018 Nov 27;16(1):218. doi: 10.1186/s12916-018-1204-6.

19.

Global genetic diversity of var2csa in Plasmodium falciparum with implications for malaria in pregnancy and vaccine development.

Benavente ED, Oresegun DR, de Sessions PF, Walker EM, Roper C, Dombrowski JG, de Souza RM, Marinho CRF, Sutherland CJ, Hibberd ML, Mohareb F, Baker DA, Clark TG, Campino S.

Sci Rep. 2018 Oct 18;8(1):15429. doi: 10.1038/s41598-018-33767-3.

20.
21.

Gametocyte Development and Carriage in Ghanaian Individuals with Uncomplicated Plasmodium falciparum Malaria.

Dinko B, Ansah F, Agyare-Kwabi C, Tagboto S, Amoah LE, Urban BC, Sutherland CJ, Awandare GA, Williamson KC, Binka FN, Deitsch KW.

Am J Trop Med Hyg. 2018 Jul;99(1):57-64. doi: 10.4269/ajtmh.18-0077. Epub 2018 Apr 19.

22.

Plasmodium-associated changes in human odor attract mosquitoes.

Robinson A, Busula AO, Voets MA, Beshir KB, Caulfield JC, Powers SJ, Verhulst NO, Winskill P, Muwanguzi J, Birkett MA, Smallegange RC, Masiga DK, Mukabana WR, Sauerwein RW, Sutherland CJ, Bousema T, Pickett JA, Takken W, Logan JG, de Boer JG.

Proc Natl Acad Sci U S A. 2018 May 1;115(18):E4209-E4218. doi: 10.1073/pnas.1721610115. Epub 2018 Apr 16.

23.

Publisher Correction: Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunity.

Stone WJR, Campo JJ, Ouédraogo AL, Meerstein-Kessel L, Morlais I, Da D, Cohuet A, Nsango S, Sutherland CJ, van de Vegte-Bolmer M, Siebelink-Stoter R, van Gemert GJ, Graumans W, Lanke K, Shandling AD, Pablo JV, Teng AA, Jones S, de Jong RM, Fabra-García A, Bradley J, Roeffen W, Lasonder E, Gremo G, Schwarzer E, Janse CJ, Singh SK, Theisen M, Felgner P, Marti M, Drakeley C, Sauerwein R, Bousema T, Jore MM.

Nat Commun. 2018 Apr 11;9(1):1498. doi: 10.1038/s41467-018-03769-w.

24.

Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunity.

Stone WJR, Campo JJ, Ouédraogo AL, Meerstein-Kessel L, Morlais I, Da D, Cohuet A, Nsango S, Sutherland CJ, van de Vegte-Bolmer M, Siebelink-Stoter R, van Gemert GJ, Graumans W, Lanke K, Shandling AD, Pablo JV, Teng AA, Jones S, de Jong RM, Fabra-García A, Bradley J, Roeffen W, Lasonder E, Gremo G, Schwarzer E, Janse CJ, Singh SK, Theisen M, Felgner P, Marti M, Drakeley C, Sauerwein R, Bousema T, Jore MM.

Nat Commun. 2018 Feb 8;9(1):558. doi: 10.1038/s41467-017-02646-2. Erratum in: Nat Commun. 2018 Apr 11;9(1):1498.

25.

A reference genome and methylome for the Plasmodium knowlesi A1-H.1 line.

Benavente ED, de Sessions PF, Moon RW, Grainger M, Holder AA, Blackman MJ, Roper C, Drakeley CJ, Pain A, Sutherland CJ, Hibberd ML, Campino S, Clark TG.

Int J Parasitol. 2018 Mar;48(3-4):191-196. doi: 10.1016/j.ijpara.2017.09.008. Epub 2017 Dec 16.

26.

Randomised controlled trial of two sequential artemisinin-based combination therapy regimens to treat uncomplicated falciparum malaria in African children: a protocol to investigate safety, efficacy and adherence.

Schallig HD, Tinto H, Sawa P, Kaur H, Duparc S, Ishengoma DS, Magnussen P, Alifrangis M, Sutherland CJ.

BMJ Glob Health. 2017 Aug 30;2(3):e000371. doi: 10.1136/bmjgh-2017-000371. eCollection 2017.

27.

Variability of Cutaneous Leishmaniasis Lesions Is Not Associated with Genetic Diversity of Leishmania tropica in Khyber Pakhtunkhwa Province of Pakistan.

Khan NH, Llewellyn MS, Schönian G, Sutherland CJ.

Am J Trop Med Hyg. 2017 Nov;97(5):1489-1497. doi: 10.4269/ajtmh.16-0887. Epub 2017 Oct 10.

28.

Comparison of the susceptibility of Plasmodium knowlesi and Plasmodium falciparum to antimalarial agents.

van Schalkwyk DA, Moon RW, Blasco B, Sutherland CJ.

J Antimicrob Chemother. 2017 Nov 1;72(11):3051-3058. doi: 10.1093/jac/dkx279.

29.

Analysis of nuclear and organellar genomes of Plasmodium knowlesi in humans reveals ancient population structure and recent recombination among host-specific subpopulations.

Diez Benavente E, Florez de Sessions P, Moon RW, Holder AA, Blackman MJ, Roper C, Drakeley CJ, Pain A, Sutherland CJ, Hibberd ML, Campino S, Clark TG.

PLoS Genet. 2017 Sep 18;13(9):e1007008. doi: 10.1371/journal.pgen.1007008. eCollection 2017 Sep.

30.

Reply to van der Pluijm et al., "Antimalarial Resistance Unlikely To Explain U.K. Artemether-Lumefantrine Failures".

Sutherland CJ.

Antimicrob Agents Chemother. 2017 Jun 27;61(7). pii: e00815-17. doi: 10.1128/AAC.00815-17. Print 2017 Jul. No abstract available.

31.

Reply to Plucinski et al., "Interpreting Data from Passive Surveillance of Antimalarial Treatment Failures".

Sutherland CJ, Gkrania-Klotsas E, Chiodini PL.

Antimicrob Agents Chemother. 2017 May 24;61(6). pii: e00529-17. doi: 10.1128/AAC.00529-17. Print 2017 Jun. No abstract available.

32.

Genomic variation in Plasmodium vivax malaria reveals regions under selective pressure.

Diez Benavente E, Ward Z, Chan W, Mohareb FR, Sutherland CJ, Roper C, Campino S, Clark TG.

PLoS One. 2017 May 11;12(5):e0177134. doi: 10.1371/journal.pone.0177134. eCollection 2017.

33.

Contribution of Plasmodium knowlesi to Multispecies Human Malaria Infections in North Sumatera, Indonesia.

Lubis IND, Wijaya H, Lubis M, Lubis CP, Divis PCS, Beshir KB, Sutherland CJ.

J Infect Dis. 2017 Apr 1;215(7):1148-1155. doi: 10.1093/infdis/jix091.

34.

Selective Whole-Genome Amplification Is a Robust Method That Enables Scalable Whole-Genome Sequencing of Plasmodium vivax from Unprocessed Clinical Samples.

Cowell AN, Loy DE, Sundararaman SA, Valdivia H, Fisch K, Lescano AG, Baldeviano GC, Durand S, Gerbasi V, Sutherland CJ, Nolder D, Vinetz JM, Hahn BH, Winzeler EA.

MBio. 2017 Feb 7;8(1). pii: e02257-16. doi: 10.1128/mBio.02257-16.

35.

pfk13-Independent Treatment Failure in Four Imported Cases of Plasmodium falciparum Malaria Treated with Artemether-Lumefantrine in the United Kingdom.

Sutherland CJ, Lansdell P, Sanders M, Muwanguzi J, van Schalkwyk DA, Kaur H, Nolder D, Tucker J, Bennett HM, Otto TD, Berriman M, Patel TA, Lynn R, Gkrania-Klotsas E, Chiodini PL.

Antimicrob Agents Chemother. 2017 Feb 23;61(3). pii: e02382-16. doi: 10.1128/AAC.02382-16. Print 2017 Mar.

36.

Malaria epidemiology in central Myanmar: identification of a multi-species asymptomatic reservoir of infection.

Ghinai I, Cook J, Hla TT, Htet HM, Hall T, Lubis IN, Ghinai R, Hesketh T, Naung Y, Lwin MM, Latt TS, Heymann DL, Sutherland CJ, Drakeley C, Field N.

Malar J. 2017 Jan 5;16(1):16. doi: 10.1186/s12936-016-1651-5.

37.

Characterizing the impact of sustained sulfadoxine/pyrimethamine use upon the Plasmodium falciparum population in Malawi.

Ravenhall M, Benavente ED, Mipando M, Jensen AT, Sutherland CJ, Roper C, Sepúlveda N, Kwiatkowski DP, Montgomery J, Phiri KS, Terlouw A, Craig A, Campino S, Ocholla H, Clark TG.

Malar J. 2016 Nov 29;15(1):575.

38.

Rescuing artemisinin combination therapy in Africa.

Sutherland CJ.

Lancet Glob Health. 2017 Jan;5(1):e8-e9. doi: 10.1016/S2214-109X(16)30291-1. Epub 2016 Nov 11. No abstract available.

39.

Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V.

Oguike MC, Falade CO, Shu E, Enato IG, Watila I, Baba ES, Bruce J, Webster J, Hamade P, Meek S, Chandramohan D, Sutherland CJ, Warhurst D, Roper C.

Int J Parasitol Drugs Drug Resist. 2016 Dec;6(3):220-229. doi: 10.1016/j.ijpddr.2016.08.004. Epub 2016 Sep 29.

40.

Cutaneous Leishmaniasis in Khyber Pakhtunkhwa Province of Pakistan: Clinical Diversity and Species-Level Diagnosis.

Khan NH, Bari AU, Hashim R, Khan I, Muneer A, Shah A, Wahid S, Yardley V, O'Neil B, Sutherland CJ.

Am J Trop Med Hyg. 2016 Nov 2;95(5):1106-1114. doi: 10.4269/ajtmh.16-0343. Epub 2016 Sep 6.

41.

Paper-Origami-Based Multiplexed Malaria Diagnostics from Whole Blood.

Xu G, Nolder D, Reboud J, Oguike MC, van Schalkwyk DA, Sutherland CJ, Cooper JM.

Angew Chem Int Ed Engl. 2016 Dec 5;55(49):15250-15253. doi: 10.1002/anie.201606060. Epub 2016 Aug 24.

42.

Persistent Parasitism: The Adaptive Biology of Malariae and Ovale Malaria.

Sutherland CJ.

Trends Parasitol. 2016 Oct;32(10):808-819. doi: 10.1016/j.pt.2016.07.001. Epub 2016 Jul 30. Review.

PMID:
27480365
43.

Genome-scale comparison of expanded gene families in Plasmodium ovale wallikeri and Plasmodium ovale curtisi with Plasmodium malariae and with other Plasmodium species.

Ansari HR, Templeton TJ, Subudhi AK, Ramaprasad A, Tang J, Lu F, Naeem R, Hashish Y, Oguike MC, Benavente ED, Clark TG, Sutherland CJ, Barnwell JW, Culleton R, Cao J, Pain A.

Int J Parasitol. 2016 Oct;46(11):685-96. doi: 10.1016/j.ijpara.2016.05.009. Epub 2016 Jul 5.

44.

Phylogenetic position of Leishmania isolates from Khyber Pakhtunkhwa province of Pakistan.

Khan NH, Messenger LA, Wahid S, Sutherland CJ.

Exp Parasitol. 2016 Aug;167:61-6. doi: 10.1016/j.exppara.2016.05.006. Epub 2016 May 24.

45.

Antibody responses to surface antigens of Plasmodium falciparum gametocyte-infected erythrocytes and their relation to gametocytaemia.

Dinko B, King E, Targett GA, Sutherland CJ.

Parasite Immunol. 2016 Jun;38(6):352-64. doi: 10.1111/pim.12323.

46.

Sensitive Detection of Plasmodium vivax Using a High-Throughput, Colourimetric Loop Mediated Isothermal Amplification (HtLAMP) Platform: A Potential Novel Tool for Malaria Elimination.

Britton S, Cheng Q, Grigg MJ, Poole CB, Pasay C, William T, Fornace K, Anstey NM, Sutherland CJ, Drakeley C, McCarthy JS.

PLoS Negl Trop Dis. 2016 Feb 12;10(2):e0004443. doi: 10.1371/journal.pntd.0004443. eCollection 2016 Feb.

47.

Lack of K13 mutations in Plasmodium falciparum persisting after artemisinin combination therapy treatment of Kenyan children.

Muwanguzi J, Henriques G, Sawa P, Bousema T, Sutherland CJ, Beshir KB.

Malar J. 2016 Jan 22;15:36. doi: 10.1186/s12936-016-1095-y.

48.

Delayed Onset of Symptoms and Atovaquone-Proguanil Chemoprophylaxis Breakthrough by Plasmodium malariae in the Absence of Mutation at Codon 268 of pmcytb.

Teo BH, Lansdell P, Smith V, Blaze M, Nolder D, Beshir KB, Chiodini PL, Cao J, Färnert A, Sutherland CJ.

PLoS Negl Trop Dis. 2015 Oct 20;9(10):e0004068. doi: 10.1371/journal.pntd.0004068. eCollection 2015.

49.

A simple, high-throughput, colourimetric, field applicable loop-mediated isothermal amplification (HtLAMP) assay for malaria elimination.

Britton S, Cheng Q, Sutherland CJ, McCarthy JS.

Malar J. 2015 Aug 28;14:335. doi: 10.1186/s12936-015-0848-3.

Supplemental Content

Loading ...
Support Center